Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Signifor (pasireotide)
i
Other names:
SOM230
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Recordati
Drug class:
SSTR agonist
Related drugs:
‹
octreotide (10)
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide extended release (0)
octreotide acetate (0)
vapreotide (0)
pasireotide long acting release (0)
Debio 4126 (0)
octreotide acetate solution for injection (0)
CAM2029 (0)
MTD201 (0)
octreotide (10)
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide extended release (0)
octreotide acetate (0)
vapreotide (0)
pasireotide long acting release (0)
Debio 4126 (0)
octreotide acetate solution for injection (0)
CAM2029 (0)
MTD201 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF wild-type + NRAS wild-type
Melanoma
BRAF wild-type + NRAS wild-type
Melanoma
Sensitive: C3 – Early Trials
Sensitive
:
C3
Sensitive: C3 – Early Trials
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login